Walleye Capital’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Walleye Capital's DFTX Position: Q3 2026 in Review
Walleye Capital increased its Definium Therapeutics (DFTX) stake by 35% in Q3 2026, buying an estimated $301K and bringing the position to 27,776 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #3429.
Walleye Capital first reported a position in DFTX in Q2 2024 and has held it in 5 quarters since. 349 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Walleye Capital held 27,776 shares of Definium Therapeutics worth $1.06M as of Q3 2026.
- Walleye Capital bought 7,133 Definium Therapeutics shares in Q3 2026, an estimated $301K.
- Definium Therapeutics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #3429 holding.
- Walleye Capital first reported a position in Definium Therapeutics in Q2 2024 and has held it in 5 quarters since.
- 349 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.